Back

Bullish Case: FDA IND allowance, desirable Alisertib trial outcomes, robust revenue from NERLYNX, and a 46% undervaluation present upside potential.


Bearish Case: Historic price declines, -92.7% 10-year return, and high P/E ratio suggest overvaluation and ongoing bearish market sentiment.


Potential Outcomes: Alisertib Phase II success (35%), continued mean reversion (60%), accelerated approval discussions (25%), negative sentiment impacting stock price (40%).


Trading Oracle: Sign Up to access trading oracle trade ideas.


April 13, 2024


Puma Biotechnology Forecast

PBYI        Puma Biotechnology
Price Forecast: BULLISH    Price Action: MEAN REVERTING (?)











Correlated Stock Forecasts

Assets that tend to move strongly with PBYI



UDOW Forecast + Options Trading Strategies   UDOW  ProShares UltraPro Dow30 (0.93)


ECL Forecast + Options Trading Strategies   ECL  Ecolab (0.93)


MAS Forecast + Options Trading Strategies   MAS  Masco (0.93)


ITB Forecast + Options Trading Strategies   ITB  BTC iShares U.S. Home Construction (0.92)


HWM Forecast + Options Trading Strategies   HWM  Howmet Aerospace (0.92)



Uncorrelated Stock Forecasts

Assets with little price relationship to PBYI



SEE Forecast + Options Trading Strategies   SEE  Sealed Air (0.0)


BYD Forecast + Options Trading Strategies   BYD  Boyd Gaming (-0.0)


U Forecast + Options Trading Strategies   U  Unity Software (-0.01)


LVS Forecast + Options Trading Strategies   LVS  Las Vegas Sands (0.01)


UAL Forecast + Options Trading Strategies   UAL  United Airlines (-0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against PBYI



SRTY Forecast + Options Trading Strategies   SRTY  ProShares UltraPro Short Russell2000 (-0.88)


TZA Forecast + Options Trading Strategies   TZA  Direxion Daily Small Cap Bear 3X Shares (-0.88)


SPXS Forecast + Options Trading Strategies   SPXS  Direxion Daily S&P 500 Bear 3X Shares (-0.91)


DXD Forecast + Options Trading Strategies   DXD  ProShares UltraShort Dow30 (-0.92)


SDOW Forecast + Options Trading Strategies   SDOW  ProShares UltraPro Short Dow30 (-0.92)





Become a more profitable investor with AI optimized trading strategies






×

Chat with PBYI


 Ask any question about PBYI!